Factors Associated with Readmission of Patients with Congenital Heart Disease in a Swiss University Hospital. by Chave, M. & Marques-Vidal, P.
  
Serveur Académique Lausannois SERVAL serval.unil.ch 
Author Manuscript 
Faculty of Biology and Medicine Publication 
This paper has been peer-reviewed but dos not include the final publisher 
proof-corrections or journal pagination. 
Published in final edited form as:  
 
In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains 
an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article. 
 
Title: Factors Associated with Readmission of Patients with Congenital 
Heart Disease in a Swiss University Hospital. 
Authors: Chave M, Marques-Vidal P 
Journal: Pediatric cardiology 
Year: 2017 Apr 
Volume: 38 
Issue: 4 
Pages: 650-655 
DOI: 10.1007/s00246-016-1562-9 
 
1 
 
FACTORS ASSOCIATED WITH READMISSION OF PATIENTS WITH CONGENITAL HEART DISEASE IN A 1 
SWISS UNIVERSITY HOSPITAL 2 
Running title: Readmission of patients with congenital heart disease 3 
Morgane Chave, student 1 and Pedro Marques-Vidal, MD, PhD, FESC1 4 
1 Department of medicine, internal medicine, Lausanne university hospital (CHUV), rue du 5 
Bugnon 46, 1011 Lausanne, Switzerland 6 
 7 
Authors’ emails: 8 
Morgane Chave: Morgane.Chave@unil.ch 9 
Pedro Marques-Vidal: Pedro-Manuel.Marques-Vidal@chuv.ch 10 
 11 
Address for correspondence and reprints 12 
 Pedro Marques-Vidal 13 
Office BH10 - 642 14 
Department of Internal Medicine, Internal Medicine 15 
 Rue du Bugnon 46 16 
 1011 Lausanne 17 
 Switzerland 18 
 Phone : +41 21 314 09 34 19 
Fax :  +41 21 314 04 51 20 
 Email :  Pedro-Manuel.Marques-Vidal@chuv.ch 21 
 22 
Funding: none 23 
The authors report no conflict of interest. 24 
 25 
Word count: 205 (abstract), 1,863 (main text) 26 
Number of tables: 3 (+4) Figures: 0  References: 15 27 
28 
2 
 
ABSTRACT 29 
Background: Congenital heart defects (CHD) lead to extensive use of healthcare resources. Still, there 30 
is little information available regarding readmission rates or associated factors. We sought to 31 
evaluate readmission rates and their determinants among patients with CHD hospitalized in a Swiss 32 
university hospital. 33 
Methods: Retrospective study using data from all non-adult (<18 years) patients hospitalised 34 
between 2002 and 2014 at the University Hospital of Lausanne with an International Classification of 35 
Diseases (ICD) version 10 code Q20 to Q25. 36 
Results: 996 patients (460 girls, 332 undergoing surgery, mean age 2.7 years) were assessed, 96 of 37 
whom (9.6%) were readmitted within 30 days after discharge. Among the 96 readmissions, 83 38 
(86.5%) were related to the CHD. Median time to readmission was 10 days (interquartile range: 6 - 39 
20) and median length of readmission was 12 days (interquartile range: 6 - 20). After multivariate 40 
adjustment, foreign nationality, greater distance to hospital and length of index hospitalisation <14 41 
days predisposed to readmission. Patients who underwent surgery were less likely to be readmitted 42 
(8.7%). 43 
Conclusion: Readmissions were frequent, almost 1 in 10 patients, and associated with several socio-44 
clinical factors. Providing patients who live far from hospital with specialized care closer to home may 45 
help reduce the rate of readmission. 46 
 47 
Keywords: Congenital heart disease; readmission; Switzerland. 48 
49 
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INTRODUCTION 50 
Congenital heart disease (CHD) is the most common form of congenital anomaly, with a live 51 
birth prevalence ranging from 5 [1,2] to over 50 per 1,000 live births [2,3]. Patients with CHD 52 
consume considerable medical resources [4,5], leading to high healthcare costs. Hospital readmission 53 
rates are now widely cited as a surrogate measure of quality of care and of healthcare costs [6]. 54 
Indeed, several studies have shown that almost 7% of children are readmitted to hospital within 30 55 
days of discharge [7], but only a few studies conducted in North America assessed readmission rates 56 
and determinants among CHD patients [8-11]. Assessing the factors associated with readmission 57 
rates is important in order to act upon them and to reduce unnecessary hospitalisations and health 58 
costs. Importantly, none of the studies took place in Europe. 59 
Thus, our objectives were 1) to evaluate the rate of readmission among patients with CHD 60 
and 2) to analyse the factors associated with readmission. 61 
MATERIALS AND METHODS 62 
Data sources and collection 63 
The Lausanne university hospital (Centre Hospitalier Universitaire Vaudois, CHUV) is large 64 
university hospital with over 1,200 beds dedicated to the care of patients living in the canton of Vaud 65 
and neighbour cantons. The CHUV has a unit specialized in paediatric CHD, and performs 66 
approximately 200 surgeries per year on CHDs. Data were extracted from the hospital records and 67 
included gender, age at examination, country of birth, canton of residence, length of stay (LOS) and 68 
all other disease codes. Readmissions were considered if the patient was readmitted ≤30 days after 69 
his/her previous hospitalization; if a patient had multiple readmissions, only the first one was 70 
considered. Due to logistic constraints (no national database on hospital stays and lack of 71 
harmonization of data between hospitals), the analysis had to be restricted to a single hospital, a 72 
procedure also performed in other studies [9,10]. 73 
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All hospitalizations with an International Classification of Diseases (ICD-10) code ranging from 74 
Q20 to Q25 recorded between the 1st of January 2002 and 30th of March 2014 at the CHUV were 75 
considered. The exact list of the ICD-10 codes included is provided in Supplementary Table 1. 76 
Inclusion and exclusion criteria 77 
Inclusion criteria were age at admission <18 years, living in Switzerland and CHD as the main 78 
cause for hospitalization. As the CHUV participates in humanitarian actions aimed at children with 79 
CHD, patients coming from other countries to benefit from CHD surgery at the CHUV were excluded. 80 
Finally, all adult (aged ≥18 years) patients were also excluded. 81 
Statistical analysis 82 
Statistical analyses were performed using Stata version 14.0 for Windows (Stata Corp, 83 
College Station, Texas, USA). Descriptive results were expressed as number of participants 84 
(percentage), as mean ± standard deviation or as median and [interquartile range - IQR] as 85 
appropriate. Bivariate analyses were performed using chi-square or Fisher’s exact test for qualitative 86 
variables and Student’s t-test or Kruskall-Wallis test for continuous variables. Multivariate analysis for 87 
readmission was performed using logistic regression and the results were expressed as Odds ratio 88 
(OR) and 95% confidence interval (CI). Tests were two-tailed and statistical significance was assessed 89 
for p<0.05. 90 
Ethical statement 91 
The study was approved by the Commision cantonale d’éthique de la recherche sur l’être 92 
humain (protocol number 32/14; decision issued January 30th, 2014). No informed individual consent 93 
was necessary as the study used only available administrative data.  94 
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RESULTS 95 
Comparison between excluded and included patients 96 
Overall, data from 1919 patients with CHD were extracted, of whom 645 (33.6%) were aged 97 
≥18 years and 278 (14.5%) were from humanitarian actions. Thus, the final sample included 996 98 
patients (51.9% of the initial extracted sample), of whom 332 (33.3%) were hospitalized for surgery. 99 
The characteristics of the final sample overall and according to surgery are summarized in table 1. 100 
Over two-thirds of hospitalizations for non-surgical reasons included children aged less than one 101 
year; similarly, over half of hospitalizations for non-surgical reasons included children with congenital 102 
malformations of cardiac septa (Table 1). A multivariate analysis showed age less than one year, 103 
congenital malformations of cardiac septa, of aortic and mitral valves and other congenital 104 
malformations of heart to be significantly and positively associated, while living far from hospital to 105 
be inversely associated with hospitalization for non-surgical reasons (Supplementary Table 2). 106 
Factors associated with readmission 107 
Of the 996 patients, 96 (9.6%) were readmitted within 30 days, 83 of which (86.5% of 108 
readmissions, 8.3% of all patients) with CHD as main diagnosis. Median [IQR] time to readmission 109 
was 10 [6 – 20] days and median [IQR] LOS for the readmission was 12 [6 – 20] days. 110 
The bivariate association between readmission for CHD or for any cause and different socio-111 
clinical factors is summarized in table 2. Patients of non-Swiss nationality or living in a canton far 112 
from Vaud had a higher readmission rate, as well as being discharged in the beginning of the week 113 
(Monday or Tuesday); conversely, index hospitalizations with a LOS>14 days had a lower readmission 114 
rate (Table 2). These findings were partly confirmed by multivariate analysis, where benefiting from 115 
surgery and LOS>14 days were significantly associated with a lower odds of readmission for CHD, 116 
while living in a canton far from Vaud was associated with a higher odds of readmission for CHD or 117 
any other cause (table 3). 118 
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Restricting the analysis to surgical patients showed day of discharge to be significantly 119 
associated with readmission on bivariate analysis (supplementary table 3), while no associations 120 
were found on multivariate analysis (supplementary table 4). 121 
DISCUSSION 122 
Our results indicate that almost one out of ten children with CHD are readmitted 30 days 123 
after a hospitalization; longer LOS of the index hospitalization and being hospitalized for surgery are 124 
associated with a lower odds of readmission, while living far from the hospital was associated with a 125 
higher likelihood of readmission. 126 
Most hospitalizations for non-surgical reasons regarded very young children (<1 year) with 127 
mild forms of CHD. Hence, it is likely these hospitalizations regarded mainly newly diagnosed CHD in 128 
hospitalized newborns that do not need (neonatal) surgery. Unfortunately it was not possible to 129 
confirm this hypothesis, as the data was anonymized prior to extraction and no access to the 130 
individual medical files could be obtained. 131 
Readmission rates 132 
Of the 996 patients, 96 (9.6%) were readmitted within 30 days, 83 of which (8.3% of all 133 
patients) with CHD as main diagnosis . These values are slightly lower than in reported by studies 134 
conducted in North America, where readmission rates ranged from 10.5% [8] to 14.1% [11]. Among 135 
surgical patients, the readmission rate was 8.7%, again lower than reported by studies that excluded 136 
all non-surgical patients (i.e. Kogon et al with 10.8% [10], Saharan et al [9] with 11.3%, and Smith et 137 
al [8] with 10.5%).  138 
The vast majority of the patients of our study (86.5%) were readmitted on basis of a cardiac 139 
diagnosis, which is higher than reported in the literature, where values range from 14.9% [10] to 140 
58.7% [11]. Among surgical patients, 75.9% of the readmissions were caused by a cardiac diagnosis, 141 
again higher than in studies including only surgical patients [9,10,8] (14.9% for Kogon et al [10], 142 
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24.8% for Smith et al [8], and 39.1% for Saharan et al [9]). A possible explanation is that issues 143 
unrelated to the underlying CHD are managed close to the patient’s home, hospitalizations in the 144 
CHUV being conducted only if related to the CHD. As there is no centralized database with medical 145 
records in canton Vaud, it is not possible to control if patients were hospitalized elsewhere. Further, 146 
it was not possible to individually interview each patient after hospitalization. Thus, future studies 147 
should try to prospectively assess status at 30 days after hospitalization among children with CHD so 148 
to include all hospitalizations occurring outside the university hospital. 149 
Factors associated with readmission 150 
Median time to readmission was 10 days, comparable to other studies, where median time 151 
to readmission ranged from 7 [9] to 12 days [11]. 152 
Patients hospitalized for surgery had lower readmission rates, a finding consistent with the 153 
literature [10,11]. A likely explanation is that paediatric surgical wards prepare more intensively the 154 
patients and their families to manage the disease than other wards, thus preventing readmissions. 155 
Other explanations include the corrective nature of surgical procedure for CHD, reducing the 156 
hemodynamic anomalies that lead to complications and therefore readmission to hospital. 157 
There is no consensus in the literature regarding day of discharge and risk of readmission: 158 
some studies reported a higher risk for end-of-week discharges [11], other studies reported a higher 159 
risk for weekday discharges [8], and other studies found no association at all [12]. In our study, 160 
discharges occurring in the beginning of the week were associated with a higher risk of readmission 161 
on bivariate analysis, although this was no longer statistically significant after multivariate analysis. 162 
Thus, our results suggest that readmission rates are not related to day of discharge. 163 
Contrary to the literature, a longer LOS was associated with a lower risk of readmission. This 164 
finding was surprising, as all studies conducted so far reported that an initial hospital LOS over 10 165 
days was associated with a higher risk of readmission [9,10,8,11]. A possible explanation is certain 166 
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reluctance among paediatricians to discharge children at the end of a week after an index 167 
hospitalisation for CHD, which would artificially lengthen the index stay. A longer LOS could also be 168 
related to a better preparation of the patient and the family to manage the disease, thus leading to a 169 
lower readmission rate. Still, it would be of interest to assess the reasons for a longer LOS and if it is 170 
related with a better preparation of the patient and the family. Another explanation is the natural 171 
timeline of complications after CHD surgery, namely the fact that pleural [13] and pericardial [14] 172 
[15] effusions usually occur within two weeks of surgery. Thus, patients who remain in hospital for 14 173 
days can have their complications treated within the same hospital stay, whereas patients discharged 174 
earlier need to be readmitted for the management of their post-operative complication. 175 
Patients living far from the hospital had a higher readmission risk than patients who live in 176 
the canton of Vaud. This could in part be explained by the fact that patients living far from the CHUV 177 
being sent because they present with more severe or complex disease or with more comorbidities, 178 
while patients presenting with a milder disease can be managed in their local hospital. Indeed, 179 
patients living far from the hospital had a higher prevalence of congenital malformations of cardiac 180 
septa (including tetralogy of Fallot) and congenital malformations of aortic and mitral valves 181 
(Supplementary table 5). Still, this higher risk persisted even after adjustment for type of disease, 182 
suggesting that other factors not accounted for might intervene. A first possible explanation is that, 183 
because of the disease, patients and their families prefer to come (or are even sent by their local 184 
caregivers) to a tertiary, university hospital in case of any complication. Another possible explanation 185 
is that patients who live far from the CHUV have had less follow-up due to lack of specialized care in 186 
their area. Interestingly, the CHUV has developed specialized consultations in other hospitals outside 187 
the Vaud canton, and it will be interesting to assess their impact on readmission rates among 188 
patients living far from the CHUV. 189 
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Study limitations 190 
The main limitation to our study is the small sample size, with few patients undergoing 191 
surgery, leading to a relatively low statistical power. Still, our study is the first one performed in 192 
Europe and the sample size is bigger than other studies on the same topic [9,10]. The fact that it was 193 
conducted in a single institution might reduce its generalizability; still, most studies on the same 194 
topic were also conducted within a single institution [9,10] or a single region [11]. Other limitations 195 
are the lack of readmission data in other hospitals, thus precluding comparisons; also, the 196 
retrospective character does not allow studying the reasons for readmission. Finally, a possible 197 
referral bias cannot be ruled out, as our institution is a referring centre for management of children 198 
with congenital heart disease; hence, it is possible that only children with the most severe forms of 199 
disease are overrepresented. Further studies are needed to increase sample size, for example by 200 
joining all data from Switzerland. 201 
Conclusion 202 
In a Swiss university hospital, slightly less than one out of ten children with CHD is readmitted 203 
within 30 days after the index hospitalization. Distance from hospital and shorter LOS significantly 204 
increase the risk of readmission. 205 
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TABLES 253 
Table 1: characteristics of the sample, overall and according to surgery. 254 
 All No surgery Surgery P-value 
N (%) 996 (100) 664 (66.7) 332 (33.3)  
Gender (%)    0.472 
Boys 536 (53.8) 352 (65.8) 184 (34.2)  
Girls 460 (46.2) 312 (67.8) 148 (32.2)  
Swiss nationality (%)    0.416 
No 438 (44.0) 286 (65.3) 152 (34.7)  
Yes 558 (56.0) 378 (67.7) 180 (32.3)  
Age (years) 2.7 ± 4.4 2.2 ± 3.9 3.8 ± 5.0 <0.001 
Age groups (%)    <0.001 
[0-1[ 615 (61.8) 454 (73.8) 161 (26.2)  
[1-18[ 381 (38.3) 210 (55.1) 171 (44.9)  
Type of disease §    <0.001 
Q20 97 (9.7) 56 (57.7) 41 (42.3)  
Q21 531 (53.3) 380 (71.6) 151 (28.4)  
Q22 55 (5.5) 38 (69.1) 17 (30.9)  
Q23 66 (6.6) 26 (39.4) 40 (60.6)  
Q24 42 (4.2) 33 (78.6) 9 (21.4)  
Q25 205 (20.6) 131 (63.9) 74 (36.1)  
Length of stay (days) 6 [2 - 14] 4 [1 - 9] 10 [5.5 - 24.5] <0.001 † 
Results are expressed as number of participants (percentage), mean ± SD or median [interquartile 255 
range]. Percentage are expressed per column for all participants, and by row for surgery / non-256 
surgery groups. Comparisons between surgery groups performed by chi-square for categorical values 257 
and Student’s t-test or Kruskal-Wallis (†) test; p-values are for a two-sided test. § ICD-10 codes: Q20, 258 
congenital malformations of cardiac chambers and connections; Q21, congenital malformations of 259 
cardiac septa; Q22, congenital malformations of pulmonary and tricuspid valves; Q23, congenital 260 
malformations of aortic and mitral valves; Q24, other congenital malformations of heart; Q25, 261 
congenital malformations of great arteries. 262 
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Table 2: bivariate analysis of the factors associated with readmission at 30 days for congenital heart 263 
disease or for any cause, non-adult patients with congenital heart disease hospitalized at the 264 
Lausanne university hospital between 1st of January 2002 and 30th of March 2014. 265 
 Congenital heart disease Any cause 
 No Yes P-value No Yes P-value 
N 913 83  900 96  
Gender (%)   0.592   0.773 
Girl 424 (46.4) 36 (43.4)  417 (46.3) 43 (44.8)  
Boy 489 (53.6) 47 (56.6)  483 (53.7) 53 (55.2)  
Surgery (%)   0.168   0.494 
No 603 (66.1) 61 (73.5)  597 (66.3) 67 (69.8)  
Yes 310 (34.0) 22 (26.5)  303 (33.7) 29 (30.2)  
Age groups (%)   0.087   0.345 
[0-1[ 571 (62.5) 44 (53.0)  560 (62.2) 55 (57.3)  
[1-18[ 342 (37.5) 39 (47.0)  340 (37.8) 41 (42.7)  
Nationality (%)   0.008   0.057 
Not Swiss 390 (42.7) 48 (57.8)  387 (43.0) 51 (53.1)  
Swiss 523 (57.3) 35 (42.2)  513 (57.0) 45 (46.9)  
Type of disease §   0.235 †   0.521 † 
Q20 90 (9.9) 7 (8.4)  89 (9.9) 8 (8.3)  
Q21 475 (52.0) 56 (67.5)  471 (52.3) 60 (62.5)  
Q22 52 (5.7) 3 (3.6)  51 (5.7) 4 (4.2)  
Q23 62 (6.8) 4 (4.8)  59 (6.6) 7 (7.3)  
Q24 40 (4.4) 2 (2.4)  40 (4.4) 2 (2.1)  
Q25 194 (21.3) 11 (13.3)  190 (21.1) 15 (15.6)  
Canton of origin   0.004   0.034 
Vaud 546 (59.8) 42 (50.6)  540 (60.0) 48 (50.0)  
Neighbour ‡ 238 (26.1) 18 (21.7)  231 (25.7) 25 (26.0)  
Other 129 (14.1) 23 (27.7)  129 (14.3) 23 (24.0)  
LOS>14 days (%)   0.005   0.055 
No 677 (74.2) 73 (88.0)  670 (74.4) 80 (83.3)  
Yes 236 (25.9) 10 (12.0)  230 (25.6) 16 (16.7)  
Day of discharge   0.009 †   0.039 † 
Sunday 51 (5.6) 3 (3.6)  50 (5.6) 4 (4.2)  
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Monday 184 (20.2) 27 (32.5)  182 (20.2) 29 (30.2)  
Tuesday 217 (23.8) 27 (32.5)  214 (23.8) 30 (31.3)  
Wednesday 150 (16.4) 7 (8.4)  147 (16.3) 10 (10.4)  
Thursday 111 (12.2) 11 (13.3)  110 (12.2) 12 (12.5)  
Friday 136 (14.9) 6 (7.2)  133 (14.8) 9 (9.4)  
Saturday 64 (7) 2 (2.4)  64 (7.1) 2 (2.1)  
Results are expressed as number of participants and (column percentage). Statistical analysis by chi-266 
square or Fisher’s exact test (†); p-values are for a two-sided test. § ICD-10 codes: Q20, congenital 267 
malformations of cardiac chambers and connections; Q21, congenital malformations of cardiac 268 
septa; Q22, congenital malformations of pulmonary and tricuspid valves; Q23, congenital 269 
malformations of aortic and mitral valves; Q24, other congenital malformations of heart; Q25, 270 
congenital malformations of great arteries. ‡, Fribourg, Geneva, Neuchâtel and Valais. 271 
272 
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Table 3: multivariate analysis of the factors associated with readmission at 30 days for congenital 273 
heart disease or for any cause, non-adult patients with congenital heart disease hospitalized at the 274 
Lausanne university hospital between 1st of January 2002 and 30th of March 2014. 275 
 CHO p-value Any cause p-value 
Gender     
Girl 1 (ref.)  1 (ref.)  
Boy 1.1 (0.68 - 1.77) 0.693 1.05 (0.67 - 1.62) 0.844 
Surgery     
No 1 (ref.)  1 (ref.)  
Yes 0.49 (0.25 - 0.97) 0.042 0.63 (0.34 - 1.18) 0.153 
Age groups     
[0-1[ 1 (ref.)  1 (ref.)  
[1-18[ 0.97 (0.56 - 1.69) 0.916 0.83 (0.49 - 1.40) 0.491 
Nationality     
Not Swiss 1 (ref.)  1 (ref.)  
Swiss 0.62 (0.38 - 1.02) 0.062 0.70 (0.44 - 1.10) 0.124 
Type of disease §     
Q20 1 (ref.)  1 (ref.)  
Q21 1.08 (0.45 - 2.62) 0.861 1.19 (0.52 - 2.73) 0.680 
Q22 0.55 (0.13 - 2.33) 0.418 0.75 (0.21 - 2.71) 0.661 
Q23 0.74 (0.19 - 2.82) 0.655 1.36 (0.44 - 4.22) 0.589 
Q24 0.60 (0.11 - 3.16) 0.545 0.55 (0.11 - 2.82) 0.477 
Q25 0.62 (0.22 - 1.72) 0.357 0.81 (0.32 - 2.04) 0.659 
Canton of origin     
Vaud 1 (ref.)  1 (ref.)  
Neighbour ‡ 1.31 (0.70 - 2.44) 0.401 1.50 (0.86 - 2.60) 0.152 
Other 2.96 (1.56 - 5.61) 0.001 2.34 (1.27 - 4.31) 0.006 
LOS>14 days     
No 1 (ref.)  1 (ref.)  
Yes 0.42 (0.20 - 0.91) 0.028 0.63 (0.33 - 1.19) 0.156 
Day of discharge     
Sunday 1 (ref.)  1 (ref.)  
Monday 3.06 (0.85 - 10.9) 0.086 2.35 (0.76 - 7.26) 0.138 
Tuesday 2.72 (0.77 - 9.62) 0.121 2.07 (0.68 - 6.30) 0.202 
16 
 
Wednesday 0.94 (0.23 - 3.89) 0.936 0.96 (0.28 - 3.26) 0.945 
Thursday 2.22 (0.58 - 8.52) 0.247 1.60 (0.48 - 5.34) 0.441 
Friday 0.99 (0.23 - 4.20) 0.991 1.00 (0.29 - 3.44) 0.996 
Saturday 0.74 (0.12 - 4.72) 0.754 0.47 (0.08 - 2.71) 0.398 
CHO, congenital heart disease. Results are expressed as odds ratio and [95% confidence interval]. § 276 
ICD-10 codes: Q20, congenital malformations of cardiac chambers and connections; Q21, congenital 277 
malformations of cardiac septa; Q22, congenital malformations of pulmonary and tricuspid valves; 278 
Q23, congenital malformations of aortic and mitral valves; Q24, other congenital malformations of 279 
heart; Q25, congenital malformations of great arteries. ‡, Fribourg, Geneva, Neuchâtel and Valais. 280 
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SUPPLEMENTARY DATA 1 
Supplementary table 1: international classification of diseases (ICD-10) codes used to define 2 
congenital heart disease. 3 
ICD-10 code Designation 
Q20 Congenital malformations of cardiac chambers and connections 
Q21 Congenital malformations of cardiac septa 
Q22 Congenital malformations of pulmonary and tricuspid valves 
Q23 Congenital malformations of aortic and mitral valves 
Q24 Other congenital malformations of heart 
Q25 Congenital malformations of great arteries 
  4 
2 
 
Supplementary table 2: factors associated with hospitalization for non-surgical reasons 5 
 
Odds ratio and (95% CI) P-value 
Gender 
 
 
Girl 1 (ref)  
Boy 0.96 (0.73 - 1.27) 0.790 
Swiss national 
 
 
No 1 (ref)  
Yes 1.06 (0.79 - 1.43) 0.684 
Canton 
 
 
Vaud 1 (ref)  
Neighbour 0.51 (0.37 - 0.71) <0.001 
Distant 0.62 (0.41 - 0.92) 0.019 
Age group 
 
 
1+ year 1 (ref)  
<1 year 2.16 (1.61 - 2.91) <0.001 
Type of disease § 
 
 
Q20 1 (ref)  
Q21 1.84 (1.16 - 2.93) 0.010 
Q22 1.60 (0.78 - 3.29) 0.198 
Q23 0.52 (0.27 - 1.00) 0.049 
Q24 2.75 (1.16 - 6.51) 0.021 
Q25 1.34 (0.81 - 2.23) 0.258 
Results are expressed as odds ratio and (95% confidence interval). Statistical analysis by logistic 6 
regression. § ICD-10 codes: Q20, congenital malformations of cardiac chambers and connections; 7 
Q21, congenital malformations of cardiac septa; Q22, congenital malformations of pulmonary and 8 
tricuspid valves; Q23, congenital malformations of aortic and mitral valves; Q24, other congenital 9 
malformations of heart; Q25, congenital malformations of great arteries.   10 
3 
 
Supplementary table 3: bivariate analysis of the factors associated with readmission at 30 days for 11 
congenital heart disease or for any cause, surgical patients with congenital heart disease hospitalized 12 
at the Lausanne university hospital between 1st of January 2002 and 30th of March 2014. 13 
 Congenital heart disease Any cause 
 No Yes P-value No Yes P-value 
N 310 22  303 29  
Gender (%)   0.932   0.977 
Girl 138 (44.5) 10 (45.5)  135 (44.6) 13 (44.8)  
Boy 172 (55.5) 12 (54.6)  168 (55.5) 16 (55.2)  
Age groups (%)   0.768   0.716 
[0-1[ 151 (48.7) 10 (45.5)  146 (48.2) 15 (51.7)  
[1-18[ 159 (51.3) 12 (54.6)  157 (51.8) 14 (48.3)  
Nationality (%)   0.393   0.914 
Not Swiss 140 (45.2) 12 (54.6)  139 (45.9) 13 (44.8)  
Swiss 170 (54.8) 10 (45.5)  164 (54.1) 16 (55.2)  
Type of disease §   0.279 †   0.715 † 
Q20 40 (12.9) 1 (4.6)  39 (12.9) 2 (6.9)  
Q21 135 (43.6) 16 (72.7)  133 (43.9) 18 (62.1)  
Q22 16 (5.2) 1 (4.6)  16 (5.3) 1 (3.5)  
Q23 39 (12.6) 1 (4.6)  37 (12.2) 3 (10.3)  
Q24 9 (2.9) 0 (0)  9 (3.0) 0 (0)  
Q25 71 (22.9) 3 (13.6)  69 (22.8) 5 (17.2)  
Canton of origin   0.746   0.939 
Vaud 147 (47.4) 10 (45.5)  144 (47.5) 13 (44.8)  
Neighbour ‡ 99 (31.9) 6 (27.3)  95 (31.4) 10 (34.5)  
Other 64 (20.7) 6 (27.3)  64 (21.1) 6 (20.7)  
LOS>14 days (%)   0.150   0.483 
No 192 (61.9) 17 (77.3)  189 (62.4) 20 (69.0)  
Yes 118 (38.1) 5 (22.7)  114 (37.6) 9 (31.0)  
Day of discharge   0.019 †   0.058 † 
Sunday 11 (3.6) 0 (0)  11 (3.6) 0 (0)  
Monday 52 (16.8) 8 (36.4)  50 (16.5) 10 (34.5)  
Tuesday 87 (28.1) 10 (45.5)  85 (28.1) 12 (41.4)  
4 
 
Wednesday 50 (16.1) 3 (13.6)  49 (16.2) 4 (13.8)  
Thursday 45 (14.5) 0 (0)  44 (14.5) 1 (3.5)  
Friday 48 (15.5) 0 (0)  47 (15.5) 1 (3.5)  
Saturday 17 (5.5) 1 (4.6)  17 (5.6) 1 (3.5)  
Results are expressed as number of participants and (column percentage). Statistical analysis by chi-14 
square or Fisher’s exact test (†); p-values are for a two-sided test. § ICD-10 codes: Q20, congenital 15 
malformations of cardiac chambers and connections; Q21, congenital malformations of cardiac 16 
septa; Q22, congenital malformations of pulmonary and tricuspid valves; Q23, congenital 17 
malformations of aortic and mitral valves; Q24, other congenital malformations of heart; Q25, 18 
congenital malformations of great arteries. ‡, Fribourg, Geneva, Neuchâtel and Valais. 19 
20 
5 
 
Supplementary table 4: multivariate analysis of the factors associated with readmission at 30 days 21 
for congenital heart disease or for any cause, surgical patients with congenital heart disease 22 
hospitalized at the Lausanne university hospital between 1st of January 2002 and 30th of March 2014. 23 
 CHO p-value Any cause p-value 
Gender     
Girl 1 (ref.)  1 (ref.)  
Boy 1.21 (0.46 - 3.16) 0.700 1.08 (0.46 - 2.50) 0.866 
Age groups     
[0-1[ 1 (ref.)  1 (ref.)  
[1-18[ 0.32 (0.10 - 1.07) 0.064 0.41 (0.14 - 1.17) 0.094 
Nationality     
Not Swiss 1 (ref.)  1 (ref.)  
Swiss 0.63 (0.22 - 1.84) 0.401 0.91 (0.37 - 2.23) 0.839 
Type of disease §     
Q20 1 (ref.)  1 (ref.)  
Q21 4.35 (0.48 - 39.8) 0.193 3.08 (0.58 - 16.5) 0.189 
Q22 2.28 (0.11 - 46.0) 0.590 1.14 (0.08 - 15.6) 0.921 
Q23 1.01 (0.05 - 18.8) 0.995 2.08 (0.29 - 15.0) 0.469 
Q24 NA  NA  
Q25 1.26 (0.12 - 13.7) 0.850 1.23 (0.21 - 7.16) 0.818 
Canton of origin     
Vaud 1 (ref.)  1 (ref.)  
Neighbour ‡ 0.70 (0.22 - 2.26) 0.556 0.91 (0.35 - 2.33) 0.837 
Other 1.28 (0.39 - 4.18) 0.679 0.97 (0.32 - 2.90) 0.952 
LOS>14 days     
No 1 (ref.)  1 (ref.)  
Yes 0.52 (0.14 - 1.90) 0.323 0.88 (0.30 - 2.60) 0.822 
Day of discharge     
Sunday 1 (ref.)  1 (ref.)  
Monday 3.34 (0.31 - 35.9) 0.320 4.53 (0.47 - 43.2) 0.190 
Tuesday 2.16 (0.23 - 20.1) 0.497 2.85 (0.33 - 24.6) 0.340 
Wednesday 1.27 (0.11 - 14.9) 0.849 1.84 (0.18 - 18.9) 0.607 
Thursday NA  0.43 (0.02 - 7.44) 0.561 
6 
 
Friday NA  0.44 (0.03 - 7.65) 0.572 
Saturday NA  NA  
CHO, congenital heart disease. Results are expressed as odds ratio and (95% confidence interval). 24 
Statistical analysis by logistic regression . § ICD-10 codes: Q20, congenital malformations of cardiac 25 
chambers and connections; Q21, congenital malformations of cardiac septa; Q22, congenital 26 
malformations of pulmonary and tricuspid valves; Q23, congenital malformations of aortic and mitral 27 
valves; Q24, other congenital malformations of heart; Q25, congenital malformations of great 28 
arteries. ‡, Fribourg, Geneva, Neuchâtel and Valais. NA, not assessable. 29 
30 
7 
 
Supplementary table 5: type of disease according to canton of residence. 31 
 Vaud Neighbour ‡ Other P-value 
N (%) 588 (59.0) 256 (25.7) 152 (15.3)  
Type of disease §    <0.001 
Q20 40 (6.8) 36 (14.1) 21 (13.8)  
Q21 347 (59.0) 111 (43.4) 73 (48.0)  
Q22 29 (4.9) 16 (6.3) 10 (6.6)  
Q23 38 (6.5) 13 (5.1) 15 (9.9)  
Q24 23 (3.9) 16 (6.3) 3 (2.0)  
Q25 111 (18.9) 64 (25.0) 30 (19.7)  
Results are expressed as number of participants and (column percentage). Statistical analysis by chi-32 
square; p-values are for a two-sided test. § ICD-10 codes: Q20, congenital malformations of cardiac 33 
chambers and connections; Q21, congenital malformations of cardiac septa; Q22, congenital 34 
malformations of pulmonary and tricuspid valves; Q23, congenital malformations of aortic and mitral 35 
valves; Q24, other congenital malformations of heart; Q25, congenital malformations of great 36 
arteries. ‡, Fribourg, Geneva, Neuchâtel and Valais. 37 
